DE MATTEIS, ELEONORA
 Distribuzione geografica
Continente #
NA - Nord America 223
EU - Europa 139
AS - Asia 62
OC - Oceania 1
SA - Sud America 1
Totale 426
Nazione #
US - Stati Uniti d'America 221
IE - Irlanda 55
SG - Singapore 48
DE - Germania 27
IT - Italia 24
CZ - Repubblica Ceca 8
FI - Finlandia 8
CN - Cina 7
GB - Regno Unito 4
AT - Austria 3
NL - Olanda 3
PH - Filippine 3
BE - Belgio 2
CA - Canada 2
IN - India 2
AU - Australia 1
BR - Brasile 1
CH - Svizzera 1
FR - Francia 1
HK - Hong Kong 1
IQ - Iraq 1
LT - Lituania 1
SE - Svezia 1
UA - Ucraina 1
Totale 426
Città #
Chandler 55
Dublin 53
Singapore 42
Boardman 24
Santa Clara 17
Kitzingen 11
Ashburn 9
New York 9
Brno 8
Munich 7
Des Moines 5
Helsinki 5
Jacksonville 5
Lawrence 5
L’Aquila 5
Menlo Park 5
Princeton 5
West Jordan 4
Bremen 3
Cagayan de Oro 3
Catania 3
Dallas 3
Lappeenranta 3
Los Angeles 3
Seattle 3
Shanghai 3
Turin 3
Wilmington 3
Brussels 2
Cambridge 2
Houston 2
London 2
Milan 2
Padova 2
San Diego 2
San Francisco 2
Vallefoglia 2
Vienna 2
Woodbridge 2
Bad Homburg 1
Beijing 1
Canberra 1
Cedar Knolls 1
Dubendorf 1
Edinburgh 1
Fort Worth 1
Hamburg 1
Hong Kong 1
Livorno 1
Niterói 1
Oakland 1
Ottawa 1
Pune 1
Rome 1
San Mateo 1
Toronto 1
Trumbull 1
Totale 344
Nome #
The COVID-19 Pandemic as an Opportunity to Improve Health Care Through a Nurse-Coordinated Multidisciplinary Model in a Headache Specialist Center: The Implementation of a Telemedicine Protocol 63
Acute and Preventive Management of Migraine during Menstruation and Menopause 54
Role of Estrogens in Menstrual Migraine 51
Targeting CGRP for migraine treatment: mechanisms, antibodies, small molecules, perspectives 50
Migraine Prevention with Erenumab: Focus on Patient Selection, Perspectives and Outcomes 49
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 37
Cranial autonomic symptoms and response to monoclonal antibodies targeting the Calcitonin gene-related peptide pathway: A real-world study 32
Menstrually associated migraine 20
MicroRNA profiling in women with migraine: effects of CGRP-targeting treatment 19
Beyond RCTs: Short-term dual antiplatelet therapy in secondary prevention of ischemic stroke and transient ischemic attack 14
Resistant and refractory migraine: clinical presentation, pathophysiology, and management 12
Defining short-term outcomes of minor ischemic stroke due to small artery occlusion in the era of dual antiplatelet treatment: A READAPT study sub-analysis 12
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort 9
Placebo and nocebo in the treatment of migraine: How much does real world effectiveness depend on contextual effects? 9
null 7
Real-world comparison of dual versus single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: a propensity matched analysis 7
Transient brain ischemic symptoms and the presence of ischemic lesions at neuroimaging - Results from the READAPT study 6
Totale 451
Categoria #
all - tutte 2.703
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.703


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 0 3 0 1 1 0 1 0 1 0 1 4
2021/202257 0 0 0 0 5 0 1 3 8 19 6 15
2022/2023153 8 11 3 15 12 19 0 10 59 1 8 7
2023/202488 6 2 6 3 3 22 1 3 1 9 2 30
2024/2025141 25 10 34 22 48 2 0 0 0 0 0 0
Totale 451